Golden Lee Scott

EVP & CHIEF MEDICAL OFFICER

Golden Lee Scott has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Apr 6, 2026.

On the most recent filing, Golden Lee Scott is listed as EVP & CHIEF MEDICAL OFFICER at PTC THERAPEUTICS, INC. Inside the rolling window, Golden Lee Scott reported no open-market purchases and 6 open-market sales totaling $1.1M in PTCT. The largest disclosed transaction in the window is a sale of 10,000 PTCT shares on Mar 5, 2026, worth $634K.

Companies traded

Other insiders at PTCT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.1M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PTCTSale$56KApr 6SEC ↗
PTCTSale$634KMar 9SEC ↗
PTCTSale$172KFeb 20SEC ↗
PTCTSale$66KJan 12SEC ↗
PTCTSale$103KJan 8SEC ↗
PTCTSale$50KJan 8SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Golden Lee Scott made?

Golden Lee Scott has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.

Which companies does Golden Lee Scott trade?

Golden Lee Scott has filed SEC Form 4 disclosures for 1 company, including PTCT.

When was Golden Lee Scott's most recent SEC Form 4 filing?

Golden Lee Scott's most recent SEC Form 4 filing on Tracefour is dated Apr 6, 2026.

What is Golden Lee Scott's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Golden Lee Scott is listed as EVP & CHIEF MEDICAL OFFICER.

What is Golden Lee Scott's total buy and sell value in the current window?

Inside the rolling retention window, Golden Lee Scott bought $0 and sold $1.1M based on SEC Form 4 filings.

What was Golden Lee Scott's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 10,000 PTCT shares on 2026-03-05, worth $634K, per SEC Form 4 filings.